The course of lupus nephritis: a clinical-pathological correlation of fifty patients.
D000293:Adolescent; D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D001485:Basement Membrane / Q000473:pathology; D001706:Biopsy; D002738:Chloroquine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D005921:Glomerulonephritis / Q000209:etiology / Q000473:pathology; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006965:Hyperplasia / Q000473:pathology; D007678:Kidney Glomerulus / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D009393:Nephritis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000473:pathology*; D011239:Prednisolone / Q000627:therapeutic use
D005938:Glucocorticoids; D002738:Chloroquine; D003520:Cyclophosphamide; D011239:Prednisolone; D015122:Mercaptopurine; D001379:Azathioprine